IQSTEL INC (IQST) Stock Fundamental Analysis

NASDAQ:IQST • US46265G2066

2.35 USD
+0.38 (+19.29%)
At close: Feb 27, 2026
2.2435 USD
-0.11 (-4.53%)
After Hours: 2/27/2026, 8:11:39 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

IQST gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 37 industry peers in the Diversified Telecommunication Services industry. IQST may be in some trouble as it scores bad on both profitability and health. IQST is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year IQST has reported negative net income.
  • In the past year IQST has reported a negative cash flow from operations.
  • In the past 5 years IQST always reported negative net income.
  • IQST had a negative operating cash flow in each of the past 5 years.
IQST Yearly Net Income VS EBIT VS OCF VS FCFIQST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2M -4M -6M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -8.38%, IQST is doing worse than 75.68% of the companies in the same industry.
  • The Return On Equity of IQST (-91.71%) is worse than 81.08% of its industry peers.
Industry RankSector Rank
ROA -8.38%
ROE -91.71%
ROIC N/A
ROA(3y)-21.03%
ROA(5y)-43.18%
ROE(3y)-66.26%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IQST Yearly ROA, ROE, ROICIQST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

1.3 Margins

  • The Gross Margin of IQST (2.90%) is worse than 89.19% of its industry peers.
  • In the last couple of years the Gross Margin of IQST has declined.
  • IQST does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 2.9%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.29%
GM growth 5Y-7.56%
IQST Yearly Profit, Operating, Gross MarginsIQST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • IQST does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, IQST has more shares outstanding
  • IQST has more shares outstanding than it did 5 years ago.
  • IQST has a worse debt/assets ratio than last year.
IQST Yearly Shares OutstandingIQST Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M
IQST Yearly Total Debt VS Total AssetsIQST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • IQST has an Altman-Z score of 3.06. This indicates that IQST is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 3.06, IQST belongs to the best of the industry, outperforming 91.89% of the companies in the same industry.
  • IQST has a Debt/Equity ratio of 0.68. This is a neutral value indicating IQST is somewhat dependend on debt financing.
  • IQST has a better Debt to Equity ratio (0.68) than 67.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF N/A
Altman-Z 3.06
ROIC/WACCN/A
WACC10.62%
IQST Yearly LT Debt VS Equity VS FCFIQST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M 8M

2.3 Liquidity

  • IQST has a Current Ratio of 0.99. This is a bad value and indicates that IQST is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.99, IQST is not doing good in the industry: 64.86% of the companies in the same industry are doing better.
  • IQST has a Quick Ratio of 0.99. This is a bad value and indicates that IQST is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.99, IQST is doing worse than 62.16% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.99
Quick Ratio 0.99
IQST Yearly Current Assets VS Current LiabilitesIQST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • The earnings per share for IQST have decreased strongly by -291.78% in the last year.
  • The Revenue has grown by 95.96% in the past year. This is a very strong growth!
  • IQST shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 73.47% yearly.
EPS 1Y (TTM)-291.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2300%
Revenue 1Y (TTM)95.96%
Revenue growth 3Y63.58%
Revenue growth 5Y73.47%
Sales Q2Q%109.24%

3.2 Future

  • Based on estimates for the next years, IQST will show a very strong growth in Earnings Per Share. The EPS will grow by 25.32% on average per year.
  • IQST is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.65% yearly.
EPS Next Y26.7%
EPS Next 2Y35.3%
EPS Next 3Y25.32%
EPS Next 5YN/A
Revenue Next Year21.45%
Revenue Next 2Y24.18%
Revenue Next 3Y17.65%
Revenue Next 5YN/A

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
IQST Yearly Revenue VS EstimatesIQST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
IQST Yearly EPS VS EstimatesIQST Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 -0.5 -1 -1.5 -2

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • IQST reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year IQST is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IQST Price Earnings VS Forward Price EarningsIQST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IQST Per share dataIQST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

  • A more expensive valuation may be justified as IQST's earnings are expected to grow with 25.32% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.3%
EPS Next 3Y25.32%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • IQST does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

IQSTEL INC

NASDAQ:IQST (2/27/2026, 8:11:39 PM)

After market: 2.2435 -0.11 (-4.53%)

2.35

+0.38 (+19.29%)

Chartmill FA Rating
GICS IndustryGroupTelecommunication Services
GICS IndustryDiversified Telecommunication Services
Earnings (Last)11-14
Earnings (Next)03-30
Inst Owners4.62%
Inst Owner Change0%
Ins Owners0.6%
Ins Owner Change0%
Market Cap10.79M
Revenue(TTM)283.17M
Net Income(TTM)-6.62M
Analysts82.86
Price Target18.05 (668.09%)
Short Float %4.69%
Short Ratio2.14
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-1.7%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-26.3%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.34%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.04
P/FCF N/A
P/OCF N/A
P/B 1.49
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.86
EYN/A
EPS(NY)-2.13
Fwd EYN/A
FCF(TTM)-0.67
FCFYN/A
OCF(TTM)-0.64
OCFYN/A
SpS61.69
BVpS1.57
TBVpS-1.52
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -8.38%
ROE -91.71%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 2.9%
FCFM N/A
ROA(3y)-21.03%
ROA(5y)-43.18%
ROE(3y)-66.26%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.29%
GM growth 5Y-7.56%
F-Score1
Asset Turnover3.58
Health
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 30.35%
Cap/Sales 0.05%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.99
Quick Ratio 0.99
Altman-Z 3.06
F-Score1
WACC10.62%
ROIC/WACCN/A
Cap/Depr(3y)97.68%
Cap/Depr(5y)135.43%
Cap/Sales(3y)0.11%
Cap/Sales(5y)0.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-291.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2300%
EPS Next Y26.7%
EPS Next 2Y35.3%
EPS Next 3Y25.32%
EPS Next 5YN/A
Revenue 1Y (TTM)95.96%
Revenue growth 3Y63.58%
Revenue growth 5Y73.47%
Sales Q2Q%109.24%
Revenue Next Year21.45%
Revenue Next 2Y24.18%
Revenue Next 3Y17.65%
Revenue Next 5YN/A
EBIT growth 1Y-844.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-154.8%
EBIT Next 3Y90.08%
EBIT Next 5YN/A
FCF growth 1Y-80.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-97.49%
OCF growth 3YN/A
OCF growth 5YN/A

IQSTEL INC / IQST FAQ

What is the fundamental rating for IQST stock?

ChartMill assigns a fundamental rating of 2 / 10 to IQST.


What is the valuation status of IQSTEL INC (IQST) stock?

ChartMill assigns a valuation rating of 1 / 10 to IQSTEL INC (IQST). This can be considered as Overvalued.


What is the profitability of IQST stock?

IQSTEL INC (IQST) has a profitability rating of 0 / 10.


What is the financial health of IQSTEL INC (IQST) stock?

The financial health rating of IQSTEL INC (IQST) is 2 / 10.